HAE NYSE
Haemonetics Corporation
1W: +1.5%
1M: +13.4%
3M: +40.5%
YTD: +50.0%
1Y: +134.1%
3Y: +34.7%
5Y: +72.8%
$119.97
+0.78 (+0.65%)
After Hours: $117.00 (-2.97, -2.48%)
Weekly Expected Move ±9.2%
$97
$108
$118
$129
$140
Credit Risk of going bust: lower than 51% of companies Debt: 17.8% of company value Bonds: $84.5M held by 32 funds → details ▾
Of US companies ranked in the middle of the pack, about 1 in 580 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $2.47 (down 98%), Haemonetics Corporation would be worth roughly what it owes.
Total debt $1.17B against a stock market value of $5.42B.
Distance to default 5.19 (Merton model): prices to 2026-10-26, balance sheet 2026-06-27, debt counted $589.6M (short-term plus half of long-term), stock volatility 48.2%; Altman Z 3.37. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.
If the stock fell to about $2.47 (down 98%), Haemonetics Corporation would be worth roughly what it owes.
Total debt $1.17B against a stock market value of $5.42B.
Distance to default 5.19 (Merton model): prices to 2026-10-26, balance sheet 2026-06-27, debt counted $589.6M (short-term plus half of long-term), stock volatility 48.2%; Altman Z 3.37. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
2 relationships2
As Filer
counterparties named
0
As Counterparty
mentioned by others
2
Rel. Types
2023-10-10
Earliest Filing
2023-10-10
Latest Filing
target: 1
acquirer: 1
Counterparties (Filed by HAE)
2 relationshipsCompanies named in HAE's SEC 8-K filings as business counterparties.
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-10-08 | Regulation FD | View | |
| 2026-08-18 | Regulation FD | View | |
| 2026-08-06 | Earnings Release; Exhibits | View | |
| 2026-07-28 | Officer/Director Change; Shareholder Vote; Exhibits | View | |
| 2026-06-05 | Regulation FD; Exhibits | View | |
| 2026-05-07 | Earnings Release; Exhibits | View | |
| 2026-05-01 | Officer/Director Change | View | |
| 2026-03-03 | Regulation FD Disclosure | View | |
| 2026-02-12 | Regulation FD Disclosure | View | |
| 2026-02-05 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2026-01-09 | Other Events; Financial Statements and Exhibits | View | |
| 2025-11-06 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-08-07 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-07-25 | Submission of Matters to a Vote of Security Holders | View | |
| 2025-05-08 | Results of Operations and Financial Condition; Costs Associated with Exit or Disposal Activities; Fi | View | |
| 2025-03-03 | Departure/Election of Directors; Appointment of Officers; Regulation FD Disclosure; Financial Statem | View | |
| 2025-02-06 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-01-14 | Other Events; Financial Statements and Exhibits | View | |
| 2025-01-03 | Departure/Election of Directors; Appointment of Officers | View | |
| 2024-12-03 | Other Events; Financial Statements and Exhibits | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR